Zhongtai Securities gave Tianyu a buy rating: the performance is expected to turn upward, and the new varieties of CDMO and API are expected to grow rapidly – yqqlm

  • Post date April 22, 2022 — 14:20 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

300702 Zhejiang Tianyu Pharmaceutical Research, Development Paper, Packaging Product Market, Exchange Securities Economy, Business, Finance

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data